Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset.

Cistaro A, Valentini MC, Chiò A, Nobili F, Calvo A, Moglia C, Montuschi A, Morbelli S, Salmaso D, Fania P, Carrara G, Pagani M.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):251-9. doi: 10.1007/s00259-011-1979-6. Epub 2011 Nov 17. Erratum in: Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):552.

PMID:
22089661
2.

Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.

Pagani M, Chiò A, Valentini MC, Öberg J, Nobili F, Calvo A, Moglia C, Bertuzzo D, Morbelli S, De Carli F, Fania P, Cistaro A.

Neurology. 2014 Sep 16;83(12):1067-74. doi: 10.1212/WNL.0000000000000792. Epub 2014 Aug 13.

PMID:
25122207
3.

Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.

Van Weehaeghe D, Ceccarini J, Delva A, Robberecht W, Van Damme P, Van Laere K.

J Nucl Med. 2016 Aug;57(8):1238-43. doi: 10.2967/jnumed.115.166272. Epub 2016 Mar 3.

4.

Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.

Matías-Guiu JA, Pytel V, Cabrera-Martín MN, Galán L, Valles-Salgado M, Guerrero A, Moreno-Ramos T, Matías-Guiu J, Carreras JL.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2050-60. doi: 10.1007/s00259-016-3434-1. Epub 2016 Jun 4.

PMID:
27262702
5.

The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.

Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):844-52. doi: 10.1007/s00259-013-2667-5. Epub 2014 Jan 21.

6.

18F-FDG-PET correlates of cognitive impairment in ALS.

Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, Cammarosano S, Ilardi A, Moglia C, Calvo A, Chiò A.

Neurology. 2016 Jan 5;86(1):44-9. doi: 10.1212/WNL.0000000000002242. Epub 2015 Nov 20.

PMID:
26590270
7.

Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis.

Pagani M, Öberg J, De Carli F, Calvo A, Moglia C, Canosa A, Nobili F, Morbelli S, Fania P, Cistaro A, Chiò A.

Hum Brain Mapp. 2016 Mar;37(3):942-53. doi: 10.1002/hbm.23078. Epub 2015 Dec 24.

PMID:
26703938
8.

Brain FDG-PET changes in ALS and ALS-FTD.

Renard D, Collombier L, Castelnovo G, Fourcade G, Kotzki PO, LaBauge P.

Acta Neurol Belg. 2011 Dec;111(4):306-9.

PMID:
22368970
9.

The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

Kew JJ, Goldstein LH, Leigh PN, Abrahams S, Cosgrave N, Passingham RE, Frackowiak RS, Brooks DJ.

Brain. 1993 Dec;116 ( Pt 6):1399-423.

PMID:
8293278
10.

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.

Marini C, Cistaro A, Campi C, Calvo A, Caponnetto C, Nobili FM, Fania P, Beltrametti MC, Moglia C, Novi G, Buschiazzo A, Perasso A, Canosa A, Scialò C, Pomposelli E, Massone AM, Bagnara MC, Cammarosano S, Bruzzi P, Morbelli S, Sambuceti G, Mancardi G, Piana M, Chiò A.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2061-71. doi: 10.1007/s00259-016-3440-3. Epub 2016 Jul 15.

11.

Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.

Yoshizawa H, Gazes Y, Stern Y, Miyata Y, Uchiyama S.

Psychiatry Res. 2014 Jan 30;221(1):78-85. doi: 10.1016/j.pscychresns.2013.10.009. Epub 2013 Oct 31.

PMID:
24262800
12.

Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?

Quartuccio N, Van Weehaeghe D, Cistaro A, Jonsson C, Van Laere K, Pagani M.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):344-54. Epub 2014 Nov 6. Review.

13.

Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.

Buhour MS, Doidy F, Mondou A, Pélerin A, Carluer L, Eustache F, Viader F, Desgranges B.

EJNMMI Res. 2017 Dec;7(1):21. doi: 10.1186/s13550-017-0267-2. Epub 2017 Mar 6.

14.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.

15.

Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.

Yamashita T, Hatakeyama T, Sato K, Fukui Y, Hishikawa N, Ohta Y, Nishiyama Y, Kawai N, Tamiya T, Abe K.

Neurol Sci. 2017 Apr;38(4):659-665. doi: 10.1007/s10072-017-2823-y. Epub 2017 Jan 24.

PMID:
28120243
16.

Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor.

Ha SW, Yang YS, Song IU, Chung YA, Oh JK, Chung SW.

Acta Radiol. 2015 Apr;56(4):482-6. doi: 10.1177/0284185114531414. Epub 2014 Apr 29.

PMID:
24782572
17.

Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study.

Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, Böttger IG, Feinendegen L.

Acta Neurol Scand. 1992 Feb;85(2):81-9.

PMID:
1574993
18.

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.

Kew JJ, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RS, Brooks DJ.

Brain. 1993 Jun;116 ( Pt 3):655-80.

PMID:
8513396
19.

Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis.

Prell T, Peschel T, Hartung V, Kaufmann J, Klauschies R, Bodammer N, Kollewe K, Dengler R, Grosskreutz J.

Clin Neurol Neurosurg. 2013 Aug;115(8):1281-7. doi: 10.1016/j.clineuro.2012.11.031. Epub 2012 Dec 23.

PMID:
23266262
20.

Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.

Van Laere K, Vanhee A, Verschueren J, De Coster L, Driesen A, Dupont P, Robberecht W, Van Damme P.

JAMA Neurol. 2014 May;71(5):553-61. doi: 10.1001/jamaneurol.2014.62.

PMID:
24615479

Supplemental Content

Support Center